Target localization and toxicity in dose-escalated prostate radiotherapy with image-guided approach using daily planar kilovoltage imaging.

about

Target localization and toxicity in dose-escalated prostate radiotherapy with image-guided approach using daily planar kilovoltage imaging.

Item

http://www.wikidata.org/entity/Q46961215

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh-hant

name

Target localization and toxici ...... ly planar kilovoltage imaging.

@en

Target localization and toxici ...... ly planar kilovoltage imaging.

@nl

type

Item

label

Target localization and toxici ...... ly planar kilovoltage imaging.

@en

Target localization and toxici ...... ly planar kilovoltage imaging.

@nl

prefLabel

Target localization and toxici ...... ly planar kilovoltage imaging.

@en

Target localization and toxici ...... ly planar kilovoltage imaging.

@nl

P1476

Target localization and toxici ...... ly planar kilovoltage imaging.

@en

P2093

A J Mundt

http://www.w3.org/2001/XMLSchema#string

A P Sandhu

http://www.w3.org/2001/XMLSchema#string

C J Kane

http://www.w3.org/2001/XMLSchema#string

F E Millard

http://www.w3.org/2001/XMLSchema#string

J K Parsons

http://www.w3.org/2001/XMLSchema#string

L G Jensen

http://www.w3.org/2001/XMLSchema#string

M D Rosario

http://www.w3.org/2001/XMLSchema#string

R A Sethi

http://www.w3.org/2001/XMLSchema#string

R K Rice

http://www.w3.org/2001/XMLSchema#string

S B Jiang

http://www.w3.org/2001/XMLSchema#string

P2860

High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients.

Comparison of daily megavoltage electronic portal imaging or kilovoltage imaging with marker seeds to ultrasound imaging or skin marks for prostate localization and treatment positioning in patients with prostate cancer.

Long-term outcome of high dose intensity modulated radiation therapy for patients with clinically localized prostate cancer.

Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference.

CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment.

Comparison of localization performance with implanted fiducial markers and cone-beam computed tomography for on-line image-guided radiotherapy of the prostate.

Intensity-modulated radiotherapy as primary treatment for prostate cancer: acute toxicity in 114 patients.

High-dose intensity-modulated radiotherapy for prostate cancer using daily fiducial marker-based position verification: acute and late toxicity in 331 patients

Acute and late toxicity in prostate cancer patients treated by dose escalated intensity modulated radiation therapy and organ tracking.

Automatic prostate localization on cone-beam CT scans for high precision image-guided radiotherapy.

P304

31-37

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.7785/TCRT.2012.500177

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2011-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49736506

http://www.w3.org/2001/XMLSchema#string

P698

21214286

http://www.w3.org/2001/XMLSchema#string